Page last updated: 2024-08-17

edetic acid and Bone Marrow Diseases

edetic acid has been researched along with Bone Marrow Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmadzadehfar, H; Essler, M; Gaertner, F; Schlenkhoff, CD; Schmidt, M	1
Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF	1
Albahary, C	1

Reviews

1 review(s) available for edetic acid and Bone Marrow Diseases

Article	Year
Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning. The American journal of medicine, 1972, Volume: 52, Issue:3 Topics: Anemia; Bone Marrow Diseases; Cell Membrane; Cell Survival; Child; Edetic Acid; Erythrocytes; Erythrocytes, Abnormal; Erythropoiesis; Hematologic Diseases; Hematopoiesis; Heme; Hemoglobinopathies; Humans; Iron; Lead; Lead Poisoning; Mitochondria; Occupational Diseases; Osmotic Fragility; Penicillamine; Porphyrias; Porphyrins; Reticulocytes	1972

Article

Year

Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning.

The American journal of medicine, 1972, Volume: 52, Issue:3

Topics: Anemia; Bone Marrow Diseases; Cell Membrane; Cell Survival; Child; Edetic Acid; Erythrocytes; Erythrocytes, Abnormal; Erythropoiesis; Hematologic Diseases; Hematopoiesis; Heme; Hemoglobinopathies; Humans; Iron; Lead; Lead Poisoning; Mitochondria; Occupational Diseases; Osmotic Fragility; Penicillamine; Porphyrias; Porphyrins; Reticulocytes

1972

Trials

1 trial(s) available for edetic acid and Bone Marrow Diseases

Article	Year
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5 Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium	1999

Article

Year

Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium

1999

Other Studies

1 other study(ies) available for edetic acid and Bone Marrow Diseases

Article	Year
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate	2016

Article

Year

Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.

Clinical nuclear medicine, 2016, Volume: 41, Issue:6

Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate

2016